{
    "paper_id": "5f5f6b8703c018b24cd38c58c6197c6fd4b71474",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [
        {
            "text": "publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "INDEX",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Cross-reference terms in italics are general cross-references, or refer to subentry terms within the main entry (the main entry is not repeated to save space). Readers are also advised to refer to the end of each article for additional cross-references e not all of these cross-references have been included in the index cross-references.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "The index is arranged in set-out style with a maximum of three levels of subheading. Major discussion of a subject is indicated by bold page numbers. Page numbers suffixed by t, f, and b refer to Tables, Figures, and Boxes respectively. vs. indicates a comparison.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "The index entries are presented in word-by-word alphabetical sequence in which a group of letters followed by a space is filed before the same group of letters followed by a letter. For example, entries beginning 'air density' are alphabetized before 'aircraft.' Prefixes and terms in parentheses are excluded from the initial alphabetization.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Where index subentries and sub-subentries pertaining to a subject have the same page number, they have been listed to indicate the comprehensiveness of the text.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "HIV/AIDS 1:16, 1:18, 1:20 malaria 1:17, 1:19e20 networks 1:19 newer models 1:18e19 policy transfer 1:19e20 polio 1:18e20 politics of public health 1:16, 1:18 priority setting 1:16 social constructionism 1:16 tuberculosis 1:18e19 Age-standardized (world) rates breast cancer 1:354, 1:357fe358f colorectal cancer 1:359f lung cancer 1:352e353, 1:355fe356f prostate cancer 1:359, 1:362f stomach cancer 1:363fe364f Aggregate effects alcohol 1:81 Aggregated surveillance 4:224e225 Aging assessment of nutritional status 1:27e28 caloric restriction 1:29 circulatory diseases. See Circulatory diseases (CDs), and aging dealing with eating problems in 1:29t definition 1:22 dehydration 1:23, 1:27 demography of biodemography 2:230 demographic and epidemiologic transitions 2:226 economics of aging 2:230e231 elderly as a subpopulation 2:231 health, disability, and active life expectancy 2:227e230 morbidity 2:228, 2:230 mortality 2:226e230 population aging 2:226e227 dietary supplements 1:28 drugenutrient interaction 1:23, 1:29 food guide pyramid 1:27f history of subject 1:22e23 human life span and elderly 1:22f influence of, on nutrition 1:23 influence of nutrition on 1:23e26 macro-and micronutrients, need for 1:23e26, 1:24te25t macronutrientemicronutrient drug interactions in elderly 1:24te25t macronutrients 1:24te27t malnutrition 1:27e28 migration and 5:596 nutrition in older adults differing from nutrition in younger adults 1:26e27 osteoporosis in 1:28e29 perspectives of nutrition in older adults 1:29 preservation of cognitive function with 4:367e368 problem of food safety in old people 1:28 reducing aging-associated problems with nutrition 1:28e29 Sarcopenia 1:23, 1:28 See also Population aging Aging populations, in prisons 5:565e566 NGOs 1:72 policy 1:72 public health 1:71e72 sponsorship 1:73 taxation 1:72e73 UN system 1:72e73 intoxication 1:296e297 and pancreatic cancer 5:395 as a risk factor for diseases and injuries 1:296e303 social and economic impacts 1:58 costs of misuse 1:58e59 crime 1:59 effects 1:59 externalities 1:58 irrationality 1:58e59 motor vehicle accidents 1:59 production losses 1:59 public spending 1:59 taxation and public policy 1:59e60 treatment 1:75 aggregate effects 1:81 alcoholism 1:75e76 anonymous 1:79 assessment 1:77 brief intervention 1:78, 1:81 dependence 1:75e76, 1:78e80 detoxification 1:78 diagnosis 1:76, 1:76t disorders 1:76e77 harmful drinking 1:75, 1:78 intervention 1:77e78 matching and patient placement 1:80 mechanisms of action 1:75e76 mediators and moderators 1:80e81 multiple substance use and dependencies 1:79e80 non-pharmacological 1:79 pharmacological 1:79 physical examination and laboratory 1:77 rehabilitation 1:78e79 self-help groups 1:80 special features influencing 1:80 Alcohol abuse 6:494 Alcohol and drug use violence/intentional injuries 7:348 work-related fatal injuries 5:319 Alcohol consumption adult per capita consumption 1:297 of recorded alcohol 1:298 of unrecorded alcohol 1:298 adult tourist per capita consumption of alcohol 1:298e299 average volume of 1:45, 1:296 burden of disease 1:45 control of 1:384 by country 1:45e47 estimating levels and patterns 1:47 factors affecting 1:297 FAO data on 1:46 and gastric cancer 3:220 global trend of 1:48e56, 1:49f, 1:50t health conditions 1:45 heavy episodic drinking 1:299 key indicators of 1:297e299 methodological issues in estimating levels and patterns 1:47e48 modeling, at population level 1:48 modeling average volume of 1:299 mortality and morbidity 1:45 per capita consumption of alcohol and prevalence of lifetime abstainers, former drinkers, and current drinkers 1:303t prevalence of current abstainers among adults 1:51f of current drinkers, former drinkers, and lifetime abstainers 1:299 of heavy episodic drinkers 1:51f and prostate cancer 6:58 three dimensions of 1:45e48 tourist 1:46e47 unrecorded consumption 1:45e46 World Health Organization's strategy to reduce 1:45 Alcohol industry 1:62 alcohol advertising 1:63, 1:66e68, 1:68f alcohol-related harm 1:66, 1:68e70 Anheuser Busch 1:62e63 commodity chain 1:68e69 Constellation brands 1:64 corporate responsibility 1:67e68 Diageo 1:64e65 global market strategies 1:65 global promotion 1:66e67 globalization and free trade agreements 1:65e66 Heineken 1:63 InBev 1:62 Pernod Ricard 1:63e64 SABMiller 1:63 social aspects organizations 1:69 treaties 1:65e66 Alcohol outlets number and densities of 2:438 Alcohol policy, effective 2:437e442 community alcohol policy interventions 2:440e441 communities mobilizing for change on alcohol (CMCA) 2:440 community trials project 2:441 STAD (stockholm prevents alcohol and drug problems) project 2:440 less developed alcohol policy 2:441 moderately developed alcohol policy 2:441 more developed alcohol policy 2:441 policies and evidence of effectiveness 2:437e440 alcohol promotion and advertising restrictions 2:439 drinking and driving policies. See",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Drinking and driving policies government alcohol retail monopolies 2:438 hours and days of retail sale 2:438 minimum drinking age of alcohol purchase 2:437e438 number and densities of alcohol outlets 2:438 responsible beverage service or sales (RBS) 2:438e439 retail price 2:437 substance abuse prevention effectiveness 2:441e442 Alcohol use esophageal cancer risk associated with 2:598 Alcohol Use Disorder and Associated Disability Interview Schedule-DSM-IV version (AUDADIS-IV) 5:58 antimicrobial drug resistance 1:133e134, 1:137e138 bacterial infections 1:129e130, 1:133, 1:135 chemotherapeutics 1:129e130, 1:137 color therapy 1:129e130 costs 1:136 germ theory 1:129 history of medicine 1:129e130, 1:133 morbidity 1:135 mortality 1:135 penicillin and golden age 1:130e133 public health programs 1:136e137 spiral effect 1:136 therapeutic delay 1:135 toxic therapy 1:135 uses 1:136 Antibiotic resistance 3:530 Antibiotic resistance shigellosis, mechanism of 6:500 Antibiotic therapy brucellosis 1:292 for pneumonia 1:526 Antibiotics 3:81t, 4:255e256 animal use of 1:143 environmental pollution with 1:144 as growth promoters 1:143 human use of 1:143 mechanism of action 1:140e141 in plant agriculture 1:143e144 Antibody-dependent cell cytotoxicity (ADCC) 2:248 Antibody-dependent enhancement (ADE) phenomenon 2:237, 2:249 Anticorruption and health reform 2:174e175 strategies in action 2:173t Antidepressants for ADHD 5:223 Antidiabetic agents 2:288e290 GLP-1 receptor agonists 2:289e290 a-glucosidase inhibitors 2:289 insulin therapy 2:291 meglitinides 2:291 metformin 2:289 sodiumeglucose transporter 2 (SGLT2) inhibitor 2:290 sulfonylureas 2:290 thiazolidinediones 2:290 Antiemetics 5:135 Antiepileptic drugs epilepsy 6:461e463 Antiepileptic therapy 3:601 Anti-fibrinolytic drugs 3:344 Antigen detection of Chlamydia 1:557 Antigenic sin phenomenon 2:248f Antigen-presenting cells (APCs) 2:247 Antigravity treadmills 3:68e69 Anti-helminthic drugs 3:570e571, 3:571t Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial 4:130 Anti-inflammatory drugs and pancreatic cancer 5:394 Anti-inflammatory therapy 3:602 Antimicrobial drug resistance 1:133e134, 1:137e138",
            "cite_spans": [
                {
                    "start": 1294,
                    "end": 1299,
                    "text": "(ADE)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Salmonella 6:431e432 Antimicrobial resistance (AMR) 1:133e137, 1:140, 1:142f, 1:145f, 6:569 antimicrobial agents and 1:140e141 in environment 1:148 in food and food-producing animals 1:147e148 in human normal flora 1:147 link between poverty and poor sanitation 1:144 in low-and middle-income countries (LMICs) 1:143, 1:151e152 macromechanisms for 1:141e148",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "ignorance of the complexity 1:141 microbial mechanisms for 1:141 acquired resistance 1:141 intrinsic 1:141 selection of resistant organisms 1:141 in small packages 2:450 societal solutions to AMR Global Action Plan 1:148 facilitating correct use of antibiotics 1:151e152 food production with a minimal use of antibiotics 1:150 innovation and research and development 1:150e152 policy interventions 1:152 reducing pollution with antibiotics from pharmaceutical industry 1:148e149 surveillance in all biological compartments 1:150 Sustainable Development Goals (SDGs) 1:148 sustainable sanitation technologies 1:149e150, 1:149f societal-level mechanisms of 1:140 transmission manure as a route of 1:145e146, 1:146t poor governance and corruption 1:146 poor surveillance systems 1:146e148 and use of antimicrobials in agriculture and aquaculture 3:157 water and sanitation crises and 1:144e145 WHO Global Action Plan against 1:144 WHO Global Report on Surveillance of 1:147e148 Antimicrobial susceptibility test 1:202f Antimicrobial therapy 5: 23, 5:23t in adults with suspected communityacquired bacterial meningitis 5:23t intestinal infections antidiarrheal agents 4:333 prevention 4:333e334 probiotics 4:334 safe water, hygiene, and sanitation 4:333 vaccines 4:333e334 Anti-M\u00fcllerian hormone. See M\u00fcllerian inhibiting substance (MIS) Anti-myelin antigen 5:167 Antioxidants 2:309, 5:129e130 vitamin C 2:559, 2:566e567 Antiparasitic therapy 3:601e602 Anti-psychiatry 5:108 Antiquity, problem of 3:196e197 Antiretroviral therapy (ART) 1: 126, 2:96e97, 3:83, 4:562, 7:450 Auarantine against diffusion of influenza 4:255 Audio-computer-assisted interviewing (ACASI) 4:601 Audiogram 3:513e514, 3:514f Audiologists 3:512 AUDIT (Alcohol Use Disorders Identification Test) 2:342 Auditory brainstem response (ABR) 3:513 Auditory evoked potentials (AEPs) 3:513 Auditory neuropathy 3:517 Australia age structures for the Indigenous and non-Indigenous populations 3:472f aging population 3:471 consumer and carer agenda for people 7:39t death rates by major causes 3:472f demography 3:470e471 economy and government 3:471 frequently identified medical and mental disorders 7:39t geography 3:470 gross domestic product (GDP) alcohol use and 2:598 dietary factors and 2:599 etiologic factors 2:598e599 fatality rates 2:594 gender differences 2:594e595 incidence and mortality rates 2:594e595, 2:595f incidence patterns and trends 2:594e598 international trends in incidence rate 2:596fe597f medical conditions and treatments 2:599 public health significance and global importance 2:601 risk and protective factors for 2:598t signs and symptoms 2:599e600 staging tests 2:600 survival among patients 2:600e601, 2:601t tests to rule out 2:600 tobacco use and 2:598 treatment 2:600e601 Evidence-informed participatory approaches to public health 6:148e149 Evidence-informed public health 6:148 Evidence-informed public health policy evidence in policy process 3:59e61, 3:60t and evidence-based public health policy 3:57e58 interest in the idea of 3:57 lack of evidence base 3:61e62 policy-making cycle 3:59f policy-relevant evidence 3:58e59, 3:59t researchers and policy makers characteristics differences between 3:61e62, 3:61t reducing the gap between 3:62e63, 3:63t Evidence-synthesis and Cochrane barriers to health-care services 5:560 causes of 5:557 defining 5:556 disparities 5:559, 5:561 and health 5:557e560, 5:558t health conditions are risk factors for homelessness 5:557e558 HIV 5:558e559 housing 5:556e558, 5:560e561 life course model of pathways into 5:558f literal 5:556 mental health 5:556e557, 5:559e560 and mortality 5:559 prevalence of 5:556e557 duration 5:557 sociodemographic characteristics of homeless persons 5:557 prevention 5:560e561 high-risk prevention 5:560e561 population-level prevention 5:561 prevention challenges 5:561 risk factor for disease 5:558e559",
            "cite_spans": [
                {
                    "start": 559,
                    "end": 565,
                    "text": "(SDGs)",
                    "ref_id": null
                },
                {
                    "start": 1041,
                    "end": 1050,
                    "text": "23, 5:23t",
                    "ref_id": null
                },
                {
                    "start": 1535,
                    "end": 1567,
                    "text": "126, 2:96e97, 3:83, 4:562, 7:450",
                    "ref_id": null
                },
                {
                    "start": 2205,
                    "end": 2210,
                    "text": "(GDP)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "adults 5:558e559 families with children 5:559 homeless youth 5:559 older adults 5:559 schizophrenia 5:556e557 social exclusion 5:557e558, 5:561 stigma 5:557e558 substance abuse 5:556e557, 5:559e560 184, 4:197 vaccination 4:182e186, 4:195e196, 4:198 vaccines. See Vaccines Immunization, ethics of 3:7e10 children 3:7e9 collective and individual perspectives, immunization programs and tensions between 3:7 cost-effectiveness analysis and considerations of justice 3:8e9 herd immunity 3:7, 3:9 new vaccines, new ethical questions 3:7 priority setting 3:7e9 public good 3:9 safety 3:8 inconveniences and burdens for participants 3:8 serious public health problems 3:7e8 vaccination 3:9 Immunoblot 5:185e186 Immunocompromised hosts, adenoviruse impacts in 1:8 Immunodeficiency-associated VDPV (iVDPV) 5:515 Immunohistochemistry 5:185e186 Immunoproliferative small intestine disease (IPSID) 4:510 Immunosuppressants 5:163e165 multiple sclerosis 5:163e165 Immunosuppression physical activity 1:36 Impaired fasting glucose (IFG) 2:285 Impaired glucose tolerance (IGT) 2:285 Impairment, Disability and Handicap (ICIDH) 2:134 Impetigo 7:90e91 Implantable cardioverter defibrillator (ICD) 7:109e110 Implicit Association Test (IAT) 6:255 Import/export control measures 1:165e167 Imprisonment and public health 5:568e569 Improved stoves 4:203e204 Improvised explosive devices (IEDs) 5:141e142 In vitro fertilization and embryo transfer (IVF-ET) 6:298e299 In vitro fertilization (IVF) treatments 5:248, 5:250",
            "cite_spans": [
                {
                    "start": 198,
                    "end": 248,
                    "text": "184, 4:197 vaccination 4:182e186, 4:195e196, 4:198",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "infertility 4:236 Inactivated polio vaccine (IPV) 5:510e511",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "in countries outside North America 5:511 in national vaccination programs 5:512 properties of 5:511 safety and efficacy 5:511e512 technology improvements 5:511e512 Inactivated vaccine (IPV) 5:521e522 Incarcerated populations 5:563e572 alternatives to imprisonment 5:569 disease transmission in prisons 5:566e567 opportunities for intervention 5:566e567 prison conditions 5:567e568 prison health management 5:567e568 prison overcrowding 5:567 risk factors 5:566 equity 5:569 harm reduction 5:566e567 health profile of incarcerated populations 5:563e566 aging populations 5:565e566 chronic conditions 5:565 hepatitis C 5:564 HIV/AIDS 5:564 infectious diseases 5:564e565 juveniles 5:565 mental health conditions 5:563e564 sexually transmitted infections (STIs) 5:565 special populations in prisons 5:565e566 substance use disorder 5:564 tuberculosis 5:564 women's health 5:565 medication-assisted treatment (MAT) 5:567 public health and human rights 5:568e569 imprisonment and human rights 5:568 imprisonment and public health 5:568e569 partnerships with generic health policy 5:86 Policy process in public health interest groups and civil society organizations 4:296, 4:299e300 state in public health policy 6:404e407 Policy/strategy 5:494t Polio agenda setting 1:18e20 anthropology and ethics 1:116e117 definition 5:509 discontinuation of polio immunization after eradication 5:518 early research 5:510 eradication 5:515e517 Salk's vaccine 5:510e511 site of pathology 5:509 in the twentieth century 5:509e510 vaccines 7:324e325 Poliomyelitis historical 5:519e526 cutter incident 5:522e523 eradication and post-polio syndrome 5:523e525 first large epidemics 5:519e520 Franklin d. Roosevelt 5:520e521 global eradication strategy 5:524 salk 5:521e523 vaccines against polio 5:521e523 in the western world 5:520e521 immunization 4:192 surveillance 7:124e126, 7:131e132 Poliomyelitis vaccine 2:316 Poliovirus 2:474e476, 2:474t, 5:509, 5:516f cell culture adaptation of 5:510 importations of 5:517e518",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Political science and sociological theories of ethnic conflict 3:38e39 Political will 5:90 Politics, and public health policy reform agenda setting 1:16, 1:18, 5:528 approaches to understanding the politics of health sector 5:529 common issues identified in political analyses 5:529e531 context and institutions 5:529 interest groups 5:530 limited public participation in policy reform 5:530 reform champions 5:530e531 timing 5:530 creating political feasibility 5:531 major theoretical treatments 5:527e529 policy implementation 5:527e528 policy process 5:528e530 politics will 5:527e528, 5:527t strategies 5:529e531 Politics will 5:527e528, 5:527t See also Aging Population attributable fractions (PAFs) 2:118e120",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "smoking 6:546, 6:549 Population growth 1950e2015 and 2015e50 5:533f human fertility 7:212, 7:214e215 impacts of 5:538e539 age structures 5:539 civil conflict and political regime 5:539 climate change 5:539 economic outcome 5:538 maternal and child health 5:538e539 population size, spatial distribution, and composition 5:539 last half-century 5:533 opposing realities 5:533e534 population projection 5:537e538 reproductive rights 6:315 in terms of demographic change 5:534e537 demographic transition 5:536e537 fertility 5:534e535 ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Secretory IgA binding protein (SpsA) 7:94 Sectors of health care 5:10 Sector-Wide Approach (SWAp) 5:494t Security 7:417e418 Sedentary behavior physical activity and 5:463 Segmented system, in Haiti 3:489e490 Segregated system",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Self-administered drug education programs for pregnant adolescents 2:374 Self-blame 6:252 Self-care 5:49 Self-directed services 4:474e475 Self-efficacy 5:42 Self-employed nurses 5:264 Self-esteem",
            "authors": [],
            "year": null,
            "venue": "Self-reported racism",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Philipp 2:537 Seminal ducts 4:534e535 deferent duct and seminal vesicle",
            "authors": [
                {
                    "first": "Ignaz",
                    "middle": [],
                    "last": "Semelweiss",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Semmelweis 2:537, 2:537f Sendai Framework for Disaster Risk Reduction 5:94",
            "authors": [],
            "year": null,
            "venue": "Senegal community health insurance",
            "volume": "2",
            "issn": "",
            "pages": "87--88",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Serial murder 6:465e471 definition 6:469 female 6:467 history 6:467e468 killer profiles 6:467e468 multicide 6:469 multiple homicide 6:467e469, 6:471 school violence 6:466e467, 6:471 serial killer 6:467e468, 6:470e471 sexual predation 6:469e470 theory and speculation 6:470e471 types and motives",
            "authors": [],
            "year": null,
            "venue": "Sequenced Treatment Alternatives to Relieve Depression (STAR*D) 7:36e37",
            "volume": "6",
            "issn": "",
            "pages": "225--226",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Service models acute care hospitals 1:2 Service organization 5:47f, 5:49e50 variables influencing 5:50e51 Service provision issues 5:88e89 cognitive disability 5:89 provision for children 5:89 provision for women 5:89 standards of care 5:89 supply of essential medicines and therapies 5:88e89 Severe acute respiratory illness (SARI) surveillance for",
            "authors": [],
            "year": null,
            "venue": "Serovar D genome 1:555 Sertoli cells 4:531, 4:533e534 Sertoli-cell-only syndrome (SCO) 4:533e534 Serum amyloid P (SAP) 4:493 Serum cholesterol cardiovascular disease 1:446 Service delivery 5:253 linking community-based programmes to 2:104e105 structure of 2:115f systems 2:104",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Severe persistent asthma 1:190 Severe traumatic brain injury early prognostic indicators of 3:379 management of patients with 3:373e376 barbiturate coma 3:376 computed tomography scan assessment 3:374 brain oxygen monitoring 3:374e376, 3:375t of trauma (ASCOT) 4:264 Severity of Dependence Scale (SDS) 4:147 Severity scoring systems 4:265 Sex differences peripheral arterial disease (PAD) 5:450 Sex education induced abortion 7:308 Sex workers 3:235 vasoocclusion 6:507e510, 6:508t Sick-role behavior 3:394 Sidestream smoke secondhand smoke (SHS) 6:455 Silent neuritis 4:394 Silent neuropathy 4:394 Silica 4:487e489 Silicosis and coal workers",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "195--196",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Social interaction skills 3:457 Social issues in infectious disease control 6:569 Social justice, infectious disease and 3:14e15 Social learning 6:494 Social media health communication on 2:205 Social medicine in Chile 4:369e370 versus public health in other Latin American countries 4:370e371 schools of public health 6:449e450 Social mobilization strategies 2:104, 2:110 Social policies, power, health, and health care 4:373 Social pragmatism 5:9 Social relations, producing 5:16e18 forms of biosocial collective life 5:17e18 Social science contributions 5:13, 6:599e604 community-based health promotion 6:607e608 critical perspectives 6:605 culture 6:606 disciplines anthropology 6:602 demography 6:603 gerontology 6:603 health education 6:602 health psychology 6:602e603 history 6:603e604 political science 6:603 sociology 6:602 ecology 6:604 environment 6:606e607 health behavior 6:606 health disparities 6:603, 6:605, 6:609 health promotion 6:604 infectious to chronic disease 6:601 interpretive studies 6:604e605 knowledge and attitudes 6:605e606 marketing 6:608 maturation of field 6:601 policy and advocacy 6:608 prevention 6:608e609 professional development",
            "authors": [],
            "year": null,
            "venue": "347e348 Social inequality and health 2:433 Social insurance 4:474 HDS 3:505 in Western Europe 7:408, 7:412",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Social support for adherence 5:41 Social well-being 7:420e422 Socialist model HDS 3:506 Society for Public Health Education (SOPHE) Code of Ethics",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Sociocultural anthropology 2:188e189 Socioeconomic inequality 2:434 Socioeconomic position cardiovascular diseases and 6:389 Socioeconomic status (SES) 4:464 and health 7:99 and influenza 4:253e254 and mental disorders 5:69e70 and schizophrenia 5:45e46 and violence/intentional injuries",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Sociolinguistic practices in clinical encounters as cultural issues in health communication 2:204 Sociological epidemiology 2:193 importance of inequality and social disruption 2:193 importance of the social",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Soft tissue sarcomas (STS) 1:435 Soft-law 3:273e274 Soil-transmitted helminth",
            "authors": [],
            "year": null,
            "venue": "STH) infections",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Soil-transmitted helminthiasis 3:561 infectious diseases, childhood clinical features and complications 1:535 etiology and epidemiology 1:534 preventive measures 1:535 treatment",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "2:514e515 Solvents agricultural health and safety 1:41 carcinogens, environmental 1:423e434 Somatic and mental disease",
            "authors": [],
            "year": 1970,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Somatic symptoms associated with mental illness 5:41e42 Somatization 5:36e37, 5:42 Somatoform disorders",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "496e497 Sound, three aspects of 3:513e514 Source-water and drinking-water regulations",
            "authors": [
                {
                    "first": "Fred",
                    "middle": [
                        "L"
                    ],
                    "last": "Soper",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Disinfectants and Disinfection By-Products (D-DBPs) Regulation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "SDWA Amendment of 1996 2:152 in United States",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "South Africa, rural, migration and spread of HIV in 5:603 South and Central America",
            "authors": [],
            "year": null,
            "venue": "diabetes mellitus in",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "South Asia burden of cardiovascular diseases in 3:302 health systems 7:1 Afghanistan 7:1e4 Bangladesh 7:4e5 Bhutan 7:1te3t, 7:4e5, 7:5t delegation of service delivery 7:7 education 7:3 expenditures 7:4e5 governance 7:6e7 health status of population 7:1e3 health systems performance 7:6 India 7:1e3, 7:1te3t, 7:5t infrastructure and human resources 7:4 institutional 7:6e7 Maldives 7:1e5, 7:1te3t, 7:5t Nepal 7:2te3t, 7:4e6, 7:6t organization of health systems 7:3e4 Pakistan 7:1, 7:1t, 7:3e5, 7:3t",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "5--6",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Sri Lanka 7:1te3t, 7:5t traditional/indigenous systems of medicine 7:8 water supply and sanitation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "85 Sowa rigpa 7:188 Spanish flu influenza 4:238",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Southern Africa",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Spermophilus (Citellus) beecheyi 5:478 Sphere handbook Humanitarian Charter",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Sphin-gosine-1-phosphate (S1P) receptors 5:167 Spinal cord disorders 4:46 Spinal injury 7:74 burden of disease 7:74e77 cost 7:77 economics 7:77 emotional and social well-being 7:76e77 epidemiology 7:74e75 etiology 7:75 implications 7:77e78 nature 7:74 physical health 7:75e76 spinal cord 7:74e77, 7:76t trauma 7:74e75 Spinal tuberculosis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Spirochete 4:500 Spongiform encephalopathy. See Transmissible spongiform encephalopathies (TSEs) Spontaneous abortion 2:188 Spontaneous generation bacteriology 1:206e207 Sporozoites 6:79e80 Sports injuries 7:79e80 athletic injury 7:79e80, 7:80t categories 7:80e81 epidemiology 7:79 exercise therapy 7:79e80, 7:82 implementation 7:81e84 international public health issue 7:79 prevention 7:82e84 risk factors 7:81e82 sports safety",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "79--80",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Spousal Assault Replication Program (SARP) 1:513 SPSS program",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "230--231",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Stachybotrys chartarum 1:214 STAD (stockholm prevents alcohol and drug problems) project 2:440 Staff mental health policy",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Standard error (SE) 1:227 Standard Material Transfer Agreements 3:278 Standardized diagnostic systems 7:29 Standardized mortality ratio (SMR) 5:303 Standards for blood transfusion services Stigma (continued) and the illness trajectory 3:508e509 perspective of society 6:44e45 psychotic disorders 7:65 scientific advances 6:49 social psychological models 6:42e43 sociological models 6:43e44 stigmatized 6:40e43",
            "authors": [],
            "year": null,
            "venue": "Stagist model of the policy making 5:528 Standard behavior therapy (SBT) 5:386 Standard deviation 1:224, 1:224f errors in 1:224e225 Standard employment 5:617",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Stop TB Strategy 7:237e238 Stop Violence in the Home campaign 1:472e473 Strategic Framework for Food Management (SFFM",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "472 Strategic National Stockpile (SNS) 1:168 Strategic purchasing 5:208 Stratified",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "health 7:104 socioeconomic status and health 7:99 stress as a health-promoting or healthdamaging factor 7:100e101 stress-related disorders 7:101e103 Stress models of psychopathology 5:69 Stress theory 5:620e621 Stress-diathesis model 5:69 Stress-induced muscle pain 7:102 Stringent drug regulatory agencies 2:604 Stroke cardiovascular disease atherothrombosis 1:446 diabetes mellitus 1:446 hormone replacement therapy 1:447 hypertension 1:446 serum cholesterol 1:446 tobacco smoking 1:446 fish and 4:624e630 obesity",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Strauss",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": ":94e95 host immune system and 7:95 pneumococcal virulence factors 7:94e95 treatment and prevention 7:95 Streptococcus pyogenes 2:418e420, 7:87e92 host and bacterial factors 7:91 life threatening infections 7:90 necrotizing fasciitis of leg 7:90f rheumatic fever and 7:91 sequelae of 7:90e92 Streptogramins 1:140 Streptomyces avermitilis 3:580 Stress 6:250e251, 6:254e256 agricultural health and safety 1:40 hypertension 4:130 and public health 7:98e105 bodily responses to stress 7:99e100 concept of stress 7:98 gender differences in stress-related health 7:103e104 health problems in modern society 7:99 positive",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "56 Stunted children 3:77e78, 7:284e285 Subdistricts 6:12 Subdural hematoma (SDH) 3:377e378 Subdural hematoma",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "377--378",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Subgenera C serotype of adenovirus 1:6 Subjective quality of life (QOL) 1:539 Subjective well-being school health promotion",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "6",
            "issn": "",
            "pages": "439--442",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Subreplacement fertility 5:534e535 Sub-Saharan Africa burden of cardiovascular diseases in 3:303e304 HIV prevalence in 2:554 Substance abuse 5:55, 5:58e59 and homelessnes 5:556e557, 5:559e560 mental health and 5:45e53 Substance Abuse and Mental Health Service Administration (SAMHSA) 4:147e148 Substance abuse prevention effectiveness 2:441e442 Substance misuse 2:366",
            "authors": [],
            "year": null,
            "venue": "Subpopulation",
            "volume": "2",
            "issn": "2",
            "pages": "501--502",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "290 Sulfur oxides outdoor air pollution 5:368 Sumatriptan 5:134 Sumatriptan nasal spray 5:136 Summary indices 2:570e571 financial burden approach 2:571 income approach 2:570e571 other indexes",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Summary measures of population health (SMPH)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Summating potential (SP) 3:516 Supervised injection facilities (SIFs) 4:172e173 Supplemental immunization activities (SIAs",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Supplier-induced demand 2:130 Supportive environments, creation of 6:186 Supportive school environment school health promotion",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Surface Water Treatment Rule (SWTR) 2:152 Surgery 2:600 abortion 7:302e303 menopause 5:27 for ovarian cancer 5:380 physical activity 1:36 Surgical sterilization 2:189 Surrogate alcohol 1:45e46 Surveillance 7:124, 7:449 active/passive 7:125 clinic-and hospital-based 7:125 communicable diseases 7:124 community-based 7:125 diagnosis and system 7:126 Ebola 7:127, 7:132e133 epidemic 7:126e127, 7:129e130, 7:132 epidemiology 7:126e127 ethical and legal aspects 7:138 EVD 7:132e133 global surveillance network 7:135e137 inaccurate and incomplete reports 7:125e126 influenza 4:238e240, 4:242e243, 7:129e131 injuries and violence 7:134e135 measles 7:132 noncommunicable diseases 7:133e134 pandemics 7:129e131 person 7:127 place 7:127 polio and eradication 7:131e132 poliomyelitis 7:124e126",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "See Cancer survival Susceptible-Infected-Removed model 4:579e580 Sushruta Samhita 2:1 Sustainability New Public Health 5:234, 5:237 urban health 3:290 Sustainable development",
            "authors": [],
            "year": null,
            "venue": "Survival",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": ":444 drinking water and sanitation 2:356e357 mental health promotions 5:94 Sustainable sanitation technologies 1:149e150 SV-40 5:522 Swedish taxation-based national health system 5:204f Sweeteners and additives 2:300",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "46 Sympathetic adrenal medullary system (SAM) 7:99e100 Synaptobrevin",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Syndromic (clinical) surveillance 4:225 Synthetic peptides 5:168 Synthetics Monitoring: Analyses, Reporting and Trends (SMART) Programme 4:147e148",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Syphilis 1:558, 5:614, 7:480 clinical presentation 7:142e143 congenital 7:143e144 diagnosis 7:140f, 7:141e142 fluctuations in epidemics 7:140e141, 7:141f as a global infection 7:141 historical background and epidemiology 7:139e141 incidence 7:140f interaction with HIV 7:143 new cases 7:141t outbreaks in industrialized countries 7:139e140, 7:145 search for the",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "37e38 Systematic immunization 2:339 Systematic reviews in public health addressing conflict of interest 7:150 applicability 7:150 context 7:149 and evidence-based public health 7:147e148 inequalities 7:149 integrating qualitative and quantitative studies 7:149 integrity of intervention 7:149 planning the review 7:148 presentation and targeted dissemination 7:150 reviews of public health intervention",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Syria",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "150--151",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Cochrane Collaboration 7:150 health-evidence.org 7:150 National Institute for Health and Clinical Excellence 7:150 US Guide to",
            "authors": [],
            "year": null,
            "venue": "Community Preventive Services",
            "volume": "7",
            "issn": "",
            "pages": "150--151",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Systemic lupus erythematosus (SLE) 4:491e493 Systemic oppression 6:249 Systolic and diastolic heart failure 3:521 Systolic heart failure on skeletal muscle aerobic function",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Zoonoses 1:203, 4:495, 6:31 brucellosis 1:281e282, 1:293 toxoplasma gondii infection",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Zoonotic disease with HEV 3:619 Zoonotic helminths 3:604 Zoonotic infections 1:122 Zoonotic pathogens, emergence of 5:246 Zoonotic reservoirs 2:396e403 Zoonotic surveillance 4:225 Z-score",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "129 preimplantation development of",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF2": {
            "text": "Entamoeba histolytica 6:64e66, 6:66f Entamoeba moshkovskii 6:64e65 Entamoeba polecki 6:64 Enteric adenoviruses 1:6e7 Enteric fever. See Typhoid Salmonella 6:429 Enteroaggregative E. coli (EAEC) 2:585e586 Enteroinvasive E. coli (EIEC) 2:585, 2:588 Enteropathogenic E. coli (EPEC) 2:586e588 Enterotoxigenic E. coli (ETEC) 2:585e586 Enteroviruses (EVs) 7:366 representative virulence traits of 2:587t vaccines in clinical development 2:592t Escherichia coli O104:H4 3:161 Esophageal adenocarcinoma (EAC) 2:594 Esophageal cancer 2:594, 3:529, 4:604e605",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "mandatory treatment 3:13e14 mandatory vaccination 3:12e13 overview 3:11 public health emergencies 3:15 quarantine 3:14 respecting rights versus promoting public health 3:11 and prevention, aspects 2:346e347 of stem cell research. See Stem cell research, Evidence-based public health 6:148e149, 7:147 Evidenced-based interventions 7:36e37",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "past and future trends 3:103e105 prevention and mitigation 3:112e113 societal impact 3:108e110 starvation 3:110e111 victims and beneficiaries 3:110 warning systems 3:111e112 FAO-Netherlands Partnership Programme (FNPP) support 2:106 FAOSTAT 1:298 Farmer Field Schools (FFS) 2:106 'Farm-to-fork' food chain 1:258 corpus luteum 3:124f, 3:125e129, 3:126f endometrial cycle 3:127, 3:129f endometrium 3:124f, 3:125, 3:127 fertile period 3:128e129 genital tract 3:123f hypothalamic-pituitary-ovarian axis, regulation of 3:124f, 3:130e131 menstruation and menstrual cycle 3:123e125 ovarian cycle 3:125e127 ovarian hormones 3:127 ovulation 3:124f, 3:125e128, 3:126f sexual intercourse 3:125, 3:127e128 Female serial murderers 6:467",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "impact on children 5:81 impact on physical health 5:81 impact on the mental health of populations 5:82 implementation of policy 5:90e91 integration of mental health with districtlevel and provincial-level health care 5:87e88 integration with primary care 5:86e87 key cross-cutting issues 5:84e85 reduction in mortality from physical illness in mentally ill people 5:85 preparedness for disasters 5:90 Mental health, resources and services 6:15e21burden of mental disorders 6:15 community mental health 6:19 current emphases in psychiatric care 6:19e20 consumer and family involvement 6:20 deinstitutionalization and care in the community 6:20 human rights 6:19e20 integration with general and primary health care 6:20 current state of mental health resources in the world 6:16 future directions 6:20e21 mental health at the international level 6:15e16 national policies and legislation on mental health 6:16e18 budgetary issues 6:17e18 mental health legislation 6:17 mental health policy 6:16e17 Project Atlas 6:16e17, 6:20 public health approach to mental health 6:15 resource allocation 6:17e18 resources for mental health services 6:18e19 facilities 6:18e19 human resources 6:19 mental health reporting systems 6:19 primary healthcare 6:18 Mental health, and substance abuse 5:45e53 of diagnostic test studies 5:121e122 fixedand random-effects model 5:119t general aspects 5:117 of individual patient data 5:121e122 meta-regression 5:120e121 of observational studies 5:122e123 PICO approach 5:117e118 publication bias 5:120 quality and reporting of 5:123 statistical methods combining binary and dichotomous data 5:119e120 heterogeneity 5:118e119 Metabolic myopathies 5:125e131antioxidants5:129e130 background 5:125 clinical presentation 5:126e128 fatty acid oxidation defects 5:127e128 glycogen storage disease 5:128 mitochondrial disorders 5:127 clinical symptoms and history suggesting 5:127t common tests for 5:128t CPT II deficiency 5:129 diagnostic testing 5:128e129 fatty acid oxidation defects 5:129 glycogen storage disease 5:129 mitochondrial disorders 5:128e129 electron transport chain 5:125, 5:129e130 exercise testing 5:128e129 forearm ischemic test 5:129 general features of the disorders and inheritance 5:125e126 fatty acid oxidation defects 5:126 glycogen storage disease 5:126 mitochondrial disorders 5:125e126 McArdle's disease 5:125e126, 5:128e130 MELAS 5:125, 5:127e128 myoadenylate deaminase deficiency 5:125, 5:128 Pompe's disease 5:126, 5:128e129 in skeletal muscle 5:125t Tarui's disease 5:126, 5:128 treatment 5:129e130, 5:130t fatty acid oxidation defects 5:130 National health systems (continued) effective systems 5:212e213 financing health care 5:201e207 formal care and lay care 5:201e202 functions of 5:201 health care provision 5:201, 5:209e211, 5:209fe210f loans, grants, and donations 5:207 out-of-pocket payments 5:206 nutrition, food security, and HIV infection 5:272 nutrition and infections 5:271e272 nutritional status, impaired 5:273e274 opportunistic infections 5:274 tuberculosis (TB) 5:272e273 vitamins 5:271e273 influence of, on aging 1:23e26 influence of aging on 1:23 macro-and micronutrients, need for 1:26 perspectives of nutrition in older adults 1:29 problem of food safety in old people 1:28 reducing aging-associated problems with 1:28e29 Nutrition assessments during CEs 4:110 Nutritional epidemiology 2:224 Nutrition-specific interventions 7:289 Opium poppy cultivation 4:153 Opportunistic infections 5:274 Oppression 6:249e250 Optimal health, defined 3:450e451 Optional Protocol to the UN Convention against Torture 7:183 Oral glucose tolerance test (OGTT) 2:285 Oral health measurement of 2:258e260 -related quality of life (OHQoL) 2:260 See also Human resources for oral health (HROH) Oral Health Impact Profile (OHIP) 2:260 Oral Health Surveys: Basic Methods 2:260 Oral Impacts of Daily Performance (OIDP) of tumors of the tongue and tonsil 5:349 ionizing radiation exposure and 5:352 lifestyle factors and 5:349 marijuana use and 5:351 occupation risk factors 5:351, 5:351t potentially malignant disorders and 5:352e353 socioeconomic status and 5:351 in solid-organ transplant recipients 5:352 survival rates in United States 5:349t Oral-killed whole-cell cholera vaccines 2:5 Ordinary least squares (OLS) national health expenditure 2:266 Organ Procurement and Transplantation Network (OPTN) 3:17 Organ transplants, ethics of 3:17e22allocation 3:20 alternatives to organ procurement and transplantation 3:20e21 altruism 3:17e18 brain death 3:17 cadaveric organ procurement 3:17e18 after circulatory determination of death 3:17e18 after neurologic determination of death 3:17 dead donor rule 3:17e18 living related and nonrelated organ donation 3:18e19 nonrelated donors 3:18e19 related donors 3:18 organ allocation system 3:20 organ recipients 3:17 procurement, alternative proposals for PBDEs 5:359f, 5:361e364PCBs5:360e363 PFOS 5:361, 5:364 tetrabromobisphenol A 5:359e360, 5:360f triclocarban 5:361e362 triclosan 5:360f, 5:361e362 wildlife 5:361, 5:365 Orientations in public health ethics 3:186t Orientia 6:370, 6:372e373 epidemiologic features of 6:371t Original antigenic sin 2:247e248 Oropharyngeal cancer (OPC) 5:348 Orthohepadnavirus 3:613e614 Oseltamivir 4:255, 7:374 OSHA Hazard Communications Standard 5:331 Oslo Diet-Heart Study 2:306 Outcome-contingent contracts (continued) health-care demand 2:219e220 Outer ear, anatomy and physiology of 3:512 Outer Space Treaty 7:406 Out-of-pocket payments 2:392e393, 2:572, Overexertion injuries 2:577 Overweight, defined 1:487 See also Obesity/overweight Ovulation 3:124f, 3:125e128, 3:126f Ovulation predictor kits 3:98 Owen, Richard 3:604 Ownership, health-care providers by 2:115t Oxamniquine 3:592 Oxazolidinones 1:140 Oxides of nitrogen 5:368 OxyContin 4:153 Ozone acute O 3 exposures, health effects of 5:375e376 health effects of long-term ozone exposure 5:376 outdoor air pollution 5:368 respiratory health effects of 5:374e375 Ozonides 3:593 P P pilus adhesion (PapG) 2:589e590 P53 3:230 PACE (program for all-inclusive care of the elderly) 4:462 Paced Auditory Serial Additions Test (PASAT) 5:151 Pacific, HIV prevalence in 2:555 Pacific states, health systems of. See East Asia domestic hygiene, influence of 2:432 effect of primary schooling on mother's beliefs about disease 2:431 indirect, or distal, factors 2:431e432 proximate pathways of influence 2:432 relative risks of death by mother's years of schooling 2:430f Sandiford's study 2:430 selectivity, confounding, and causation 2:429e431 sociopsychological factors 2:431e432 statistical association between 2:429e430 transition from very high to lower mortality 2:429 Parenteral antischistosomal therapy (PAT) 6:274e275 Parenteral heat-phenol-inactivate whole-cell vaccine 7:282 Parent-proxy reported QOL 1:540 Paromomycin 6:68, 6:91 Partial Test Ban Treaty (PTBT) 7:406 Permissible exposure limits (PELs) 2:508 Perpetrators, types of 1:166 Persian Gulf War (1991) 5:139e143 Persistent diarrhea 1:527e528 Personal computer access 1:546 Personal harm prevention 4:162e163 Pesticides 3:158, 3:171, 5:141, 5:454e462 Acceptable Operator Exposure Level (AOEL) 5:460 Acute Reference Dose (ARfD) 5:460 acute toxicity 5:454, 5:460 agricultural health and safety 1:41e42 agriculture 5:454e456, 5:458e459, 5:461 biological monitoring 5:457e458 carcinogenicity 5:458e459 carcinogens, environmental 1:432e435 characteristics and trends of human exposure to 5:455e456 chemical pesticides 5:456t classification 5:455t dermatitis 5:459 effects on children 5:459 environmental health 2:494 environmental monitoring 5:457 health surveillance 5:461 long-term neurological effects 5:459 nomenclature and classification of 5:455 occupational health care structures 5:458 pesticide exposure monitoring 5:457e458 public health 5:454e456 strategies for prevention of pesticide risks 5:460e461 post-marketing phase 5:460e461 pre-marketing phase 5:460 toxic effects of pesticides 5:458e459 health benefits 1:32e34, 5:463e468 improvements in mental health 5:467e468 increased length of life 5:468 lower risk of cancer 5:464e465 lower risk of cardiovascular disease 5:465e466 lower risk of osteoporosis 5:466e467 lower risk of type 2 diabetes 5:466 weight control 5:467 health promotion 5:469 heart disease 5:465e466 hypertension 4:127e128 life expectancy 1:31, 1:33e34, 1:34t light, moderate, and vigorous physical activity 5:463t optimal level of physical activity for overall health 5:468 osteoporosis 5:463, 5:470 public health 1:31 quality of life 1:31, 1:34 and risk of premature death 5:468f risk reduction 5:463t risks 1:36 safety issues 5:470 Physical ergonomics 2:579e581 manual materials handling and NIOSH lifting equations 2:579e581 guidelines for lifting 2:580e581 other physical ergonomic domains: from slips and trips to lighting 2:581 upper extremity tasks and workstation designs 2:581 Physical hazards 5:141 military health issues 5:141 Physical health happiness, health and altruism 3:355e356 impact of mental health policy on 5:81 mental health and 5:35e44 Physical illness, major depression comorbidity with 5:46f Physical inactivity cardiovascular diseases and 6:387e388 Physical threats military health issues 5:141e142 Physical well-being 7:419, 7:421 Physical/sexual assault 1:473 Physician competition 2:129e130 Physician for Human Rights (PHR) report 7:182 Physician-assisted death 3:47e54 Physicianepatient relationship versus Internet 3:416 Physicians acute care hospitals 1:2e3 Physiologically based pharmacokinetic (PBPK) models 3:364 Phytochemicals 2:301, 2:310 Pick's disease 4:367 Pickwickian syndrome and childhood obesity 1:496 long-term health consequences 1:496 persistence (tracking) of obesity 1:496 PICO approach 5:117e118 Picobirnaviruses 7:365 Pink disease 5:114 Pinta (Treponema carateum) 7:476 Impact of the pandemic 1346ec.1670 5:486e488 late medieval and early modern plague pandemic, 1346ec.1670 5:483e485 late medieval population minimum 5:486 pandemic of 541e767 5:481e482 historical impact 5:482e483 population losses, 541e767 5:482 rationale for importance of 5:473e474 Plagues 1:122e123, 6:229e231 Black Death 5:476e477, 5:483e484 mortality of 5:485 black rats 5:475e476, 5:478, 5:480 conquest of 5:485 early history of 5:479 early-phase transmission 5:478e479 fight against 2:533 human plague 5:478 'metastatic leaps' of 5:475 plague bacteria 5:476 pneumonic plague 5:476 primary bacteremic plague 5:477e478 primary pneumonic plague 5:477 managing the tension between planning techniques and the politics of planning 5:498 responding to increasing international influences 5:498 changing environment 5:491e492 context of health planning 5:490e492 decision making 5:489e490 developing and harnessing new approaches to 5:499 health planning 5:489 definition 5:489 historical roots 5:489 main features 5:489 links between planning and other decisionmaking processes 5:490 planning for decentralization 5:492 planning spiral 5:494, 5:496f planning within fragile and transitional countries 5:492 publiceprivate mix and regulatory role of public sector 5:492 scaling up for development goals 5:498e499 specific inputs/resources 5:497 Planning and resourcing specialist services, policy on 5:88 Plant agriculture, antibiotic use in 1:143e144 Plaque indices 2:259 Plaque reduction neutralization test (PRNT) 2:253 Plasma exchange (PLEX). See Plasmapheresis Plasma expanders 1:247 Plasmapheresis 5:159te160t, 5:162 Plasmid-encoded resistance mechanisms 1:141 Plasminogen activator inhibitors 3:344 Plasmodium falciparum 6:106 chloroquine-resistant 6:111t Plasmodium malariae 6:103, 6:106, 6:108e109 Plasmodium ovale 6:103, 6:106e108 Plasmodium vivax 6:103e104, 6:106e109 Plausible minimum risk 2:118 medical pluralism. See Medical pluralism and professionalization 7:187e188 Pneumococcal disease immunization 4:194e195 Pneumococcal surface protein A (PspA) 7:94 Pneumococcal vaccine 1:524, 7:95 Pneumoconiosis 4:487e488 asbestos 1:178 Pneumocystis carinii pneumonia (PCP) 3:83",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "Pollution urban health 3:285e287, 3:289e290 Pollution control and water treatment 2:157e158 drinking water treatment processes 2:158 See also Source-water and drinking-water regulations Polyacrylamide chemical structure of 3:157f Polybrominated diphenyl ethers (PBDEs) organohalogens 5:359f, 5:361e364 Polychlorinated biphenyls (PCBs) 3:171, Pompe's disease 5:126, 5:128e129 Pompidou Group of the Council of Europe 4:149 Popular epidemiology 2:195",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "Population stratification, defined 3:248t Population-attributable risk (PAR) 4:380 bladder cancer 1:237 cardiovascular disease 1:441e442 Population-based services, evaluation of 5:545e546 Population-based surveillance 4:224 Population-based survival cancer survival 1:406, 1:416, 1:419e420 Population-level interventions to prevent overweight/obesity 5:386e387 Populations at health risk 3:360 Populations at special health risk. See Homelessness. See Incarcerated populations. See Indigenous populations. See Migrants. See Women's health. See Workers Positive health 7:104 Positive mental health 5:93e95, 5:98 Positive predictive value (PPV) 1:391 Positive psychology happiness, health and altruism 3:356 Positron emission tomography (PET) 2:600 Post-abortion care unsafe abortion 7:309 Postcoital intrauterine device 3:100 Poster campaigns 6:187 Postexposure prophylaxis (PEP) 6:236, 6:241e243, 6:241t Post-kala-azar dermal leishmaniasis (PKDL) Potential Years of Life Lost (YLLs) (PYLL) 3:257 Potential years of productive life lost (PYPLL) 2:363 Potentially malignant disorders 5:352e353, 5:352t Poverty 5:609, 7:418 and antibiotic resistance 1:144 insufficient access to proper health-care service 1:144 malnutrition 1:144 among women 7:436e437 and education 5:81 HIV 4:48, 4:55 and mental health 5:45e46 and poor nutritional outcomes 7:288 resource allocation 4:316e318 social epidemiology 6:575e576 Poverty Reduction Strategy Papers (PRSPs) 5:494t Power to alter the built environment 3:193 to alter the flow of information 3:193 to alter the socioeconomic environment 3:193 to directly regulate persons, professions, and businesses 3:193 to tax and spend 3:192e193 Practical ethical discourse, styles of 3:186e188 Practical significance 1:232 Praziquante 3:549 Praziquantel 3:592e593, 3:598, 3:601e602 Preamble to the UN Charter principles of health 7:418 Precarious employment 5:617 Premature death, in men 5:584 Premature menopause 5:26e27 Premature ovarian failure (POF) 3:343 Prematurity 2:188 neonatal mortality 4:218 Premenopausal breast cancer 5:285 Premenstrual dysphoric disorder (PMDD) 3:348 Premenstrual syndrome (PMS) 3:348e349 Prenatal screening 3:29 Preparedness 4:107e108 Prepartum depression 7:439 Present State Examination (PSE) 5:56 President's Emergency Plan for AIDS Relief (PEPFAR) 3:241 Price and availability of selling products 2:369e370 alcohol, evidence on 2:369e370 illicit drugs, evidence on 2:370 tobacco, evidence on 2:369 Primaquine 6:110t Primaquine phosphate 6:85 Primary bacteremic plague 5:477e478 Primary Care Evaluation of Mental Disorder (PRIME-MD) 5:56 Primary CNS lymphoma (PCNSL) clinical presentation and diagnosis 4:37 overview 4:36 treatment 4:37 Primary cutaneous marginal B-cell lymphoma (PCBCL) tissue 4:510 Primary health care (PHC) 1:83e85, 1:87, different interpretations of PHC 6:6 policy context of PHC 6:5 progress in health systems development 6:8 progress in implementing the eight program elements of PHC 6:6e7 progress with human resources for primary health care 6:8e9 and Brundtland 1:90 building health systems based on 1:94 and Chan 1:95 in a changing world 1:91 community health workers (CHW) 6:5e6, 6:9, 6:12e13 T T cells 2:249 Tacrolimus/FK50 5:165 Taenia saginata 3:598 Taenia solium 3:162, 3:597e598 life cycle of 3:597e598, 3:597f Taeniasis 3:598 Taiwan, health system in assessment of system performance 4:523e525 health and health care 4:515e516 organization and delivery of care 4:522 rising to challenges 4:526e527 Taller height and health 4:467e468 Taller people have greater longevity, studies showing 4:465 Tamoxifen 5:28 Tapeworm 3:597e598 TARGeted Intraoperative radio-Therapy (TARGIT) 1:277e278 Targeted measures of HRQOL 4:570e571 Tarui's disease 5:126, 5:128 Tattooing 5:566 Taubenberger, Jeffrey 4:256 Taxation 5:202e204, 5:204f Tax-based financing 4:473e474 Tay-Sachs disease 3:394 T-cell Vaccination (TCV) 5:167 Technical Aids for Persons with Disabilities e Classification and Terminology 4:310 Technical Barriers to Trade Agreement (TBT pancreatic cancer 5:391e392 Togaviridae 1:155 Tolfenamic acid 5:134 Tongui bogam 7:189 Tooth wear 2:259 Tooth Wear Index 2:259 Topotecan 5:381 Torovirus 7:365 Tort system, indirect regulation through 3:193e194 Torture Article 14 of the Convention against 7:183e184 CIA torture program 7:183t common psychological responses to 7:182t definition 7:178 epidemiology 7:178 European Convention for the Prevention of Torture, 1989 7:183 examples of the forms of 7:182t health professional standards on 7:183t international instruments on the absolute prohibition of 7:179te180t legal frameworks for reporting and responding to 7:182e184 Optional Protocol to the UN Convention against Torture 7:183 physical findings in torture survivors 7:181t prevalence of 7:181t prevention of 7:182 by Amnesty International 7:183t as a public health problem 7:180e181 research on 7:184 treatment and rehabilitation of survivors 7:184 Total Coliform Rule (TCR) 2:152 Total Exposure Assessment Methodology (TEAM) 4:77e78 Total homocysteine (tHcy) 3:200e201 Total trihalomethanes (TTHMs) 2:152 Tourette's Syndrome (TS) 5:225e226 Toxoplasma gondii 3:156, 3:163e166, 3:170, 6:114 biological treatments 6:125 bone marrow transplants 6:125 cardiac and kidney transplants 6:125 congenital toxoplasmosis 6:117e118 evidence-based guidelines 6:123e124 French screening policy 6:119 maternal infection 6:119e120 negative diagnosis 6:121e122 pregnancy 6:122 primary prevention 6:119 prophylaxis 6:123 prevalence 6:114e115 prevention 6:127 retinochoroiditis 6:114, 6:118, 6:124e126 risk factors 6:116e117 spiramycin 6:123, 6:125 diagnosis of 1:559e560 education and risk for 1:561 environmental improvement for preventing 1:563 facial cleanliness and 1:563 gender and risk for 1:561 global distribution of active 1:559f magnitude 1:558 management of 1:562e563 patterns of distribution 1:560 risk factors for active 1:560e561 surgical correction 1:562 Trachomatous conjunctival scarring (TS) 1:560 Trachomatous inflammationefollicular (TF) 1:560 Trachomatous inflammationeintense (TI) 1:560 Trachomatous trichiasis (TT) 1:560 Trade-offs, addressing among environment, health, and development 4:362e363 Traditional Asian medical systems 7:187e194 religious and ritual healing 7:190e191 safety and efficacy of 7:191e192 Traditional birth attendants (TBA) 6:353 Traditional Eastern medicine 7:188 Traditional healers health-care demand 2:219e220 Traditional medicine (TM) 5:8 in MENA region 6:352e353 See also Integrative medicine (IM)/ traditional and complementary medicine (T&CM) Trafficking 5:595 Tranexamic acid 3:344 Transcobalamin (TC) 3:200e201 Transcription-mediated amplification (TMA) 1:557 Transdermal patch 3:95 Transdisciplinarity and realism 6:553e554 Trans-fatty acids 2:306, 3:119e120 Transfer control measures 1:165e167 Transforming growth factor-beta (TGF-?) 3:226 Transfusion therapy, preventive measures to reduce 1:249 Transient ischemic attack (TIA) 1:462 Transitional-cell carcinoma (TCC) 1:233 Transmissible diseases 6:229e230, 6:232 Transmission/disequilibrium test (TDT) 3:251f Transparency corruption and 2:172e173 of government actions and decision-making 6:564 Transparency and Accountability Policy (TAP) 2:174 Transplantation of Human Organs Act of 1994 3:20 Transplantation of organs and tissues 3:271 Transposon-encoded resistance mechanisms 1:141 Transregional medical flows 7:187 Transtheoretical model 5:42e43 Trauma agricultural health and safety 1:39e40 brain tumors 1:268 deaths due to 4:140 illicit drugs 4:140 PTSD. See Posttraumatic stress disorder (PTSD) spinal injury 7:74e75 Trauma and injury severity score (TRISS) 4:264 Traumatic Coma Data Bank (TCDB) 3:372 Traumatic events military health issues 5:142 Traumatic parenchymal lesions 3:378 Traveler's diarrhea 4:327 integration of cancer services within the health-care system 3:211f marketed targeted therapies, cost per year 3:209t personalized medicine 3:210 predicted new drug application dates for molecular therapies 3:208f uncertainty of novel drugs for cancer Treatment Action Campaign (TAC) 4:388 Treatment choices based on taste 5:9e10 Treatnet 4:166 Treaty law 3:269 Treaty of Waitangi 3:477 T-regulatory (Treg) cell 3:226 Trend analysis of alcohol consumption by age and gender 1:52 in European countries 1:52 in terms of socioeconomic development 1:52 Trends acute care hospitals 1:3 Trentina 6:230 Treponema pallidum 1:201e202, 1:207 Treponemal diseases, epidemiologic and clinical characteristics of 7:479t Trial of Nonpharmacologic Interventions in the Elderly (TONE) trial 4:126 Triatoma dimidiata 6:70 Triatoma infestans 6:70 Trypanolytic crisis 6:60 Trypanosoma brucei 6:60 Trypanosoma cruzi 6:70, 6:73 discrete typing units 6:70e71 etiological treatment 6:75e77 Trypanosomes 6:60 Ttonsillitis 1:6 Tuberculin skin testing (TST) 7:247e248 Tuberculosis (TB) 1:122e123, 1:126e127,",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "health patterns/issues 6:348e351 emerging diseases 6:351 epidemiological and demographic transitions 6:348e351 income and health indicators for 6:348t organization of health systems 6:351e353 biomedical health systems 6:351e352 human resources issues in MENA health systems 6:353 pharmaceuticals and medical equipment and technology 6:353 traditional medicine (TM) 6:352e353 regional overview 6:347e348 road traffic accidents (RTAs) 6:350 tobacco consumption prevalence of 6:350t Middle East respiratory syndrome (MERS) 2:448 Middle East respiratory syndrome coronavirus (MERS-CoV) 2: 449, 4:222, 6:351, 6:354, 7:368 Migraine in an emergency situation 5:136 burden of 5:133 cause of 5:133 in children and adolescents 5:132, 5:136 classification of 5:133t clinical picture 5:132 concordance rates for 5:132e133 diagnosis 5:133e135 diagnostic criteria for 5:132, 5:132t epidemiology 5:132e133 genetics 5:132e133 menstrual 5:136 origin of pain in 5:134 pathophysiology 5:134 preventive therapy 5:135 treatment 5:135t active therapy 5:134 analgesics 5:134e135 antiemetics 5:135 ergot alkaloids 5:135 novel pharmacological treatments 5:136e137 'stratified care' versus 'stepped care' 5:134 triptans (5-HT1B/1D-agonists) 5:135 Migrants 5:591e598 changing motives for 5:591e592 definition of 5:591 effects on health-care systems 5:596e597 brain drain in health care 5:596 brain gain in health care 5:596 challenges for public health in countries of immigration 5:596e597 and health 5:592e596 access to health services 5:594e595 exposures in country of immigration 5:593 exposures in country of origin 5:592e593 healthy migrant effect 5:593 irregular migration and trafficking in persons 5:595 migration and aging 5:596 migration and gender 5:594 migration and reproductive health 5:595e596 patterns of mobility 5:593 psychosocial problems particular to migrants 5:595 social class 5:593e594 working conditions 5:595 infectious diseases 5:592e594 number of migrants globally and sex distribution 5:591 work migration 5:596 Migration 5: 536, 5:592, 7:437 and gender 5:594 Mild cognitive impairment (MCI) and dementia 4:365, 4:365f Mild persistent asthma 1:190 Military health issues 5:138e144combat 5:138e139 deployment 5:138f, 5:139e142 environmental and occupational health hazard issues 5:138e139 military service characteristics 5:139 training and advancement 5:139 life-cycle health 5:138, 5:138f, 5:143 longer-term health issues 5:142e143 long-term health 5:143 postdeployment health and injury issues 5:142e143 occupational and environmental health hazard issues 5:139e142 chemical hazards 5:140e141 chemical warfare agents 5:140 combustion products 5:140e141 depleted uranium 5:141 harsh environments 5:141 living conditions 5:142 noise 5:141 operational demands 5:142 pesticides 5:141 physical hazards 5:141 physical threats (accidents, explosions) 5:141e142 role of risk and resilience factors 5:142 situational hazards 5:141e142 genetics 5:146 infectious agents 5:146 evoked potentials 5:157 hormones 5:146e147 immunomodulation 5:158 immunopathogenesis 5:148e150, 5:149f magnetic resonance imaging 5:156e157 and MS variants 5:153te154t neuroimaging 5:151e152, 5:158, 5:168 new generation of immunotherapies 5:165e168 experimental treatment approaches 5:167e168 monoclonal antibodies 5:165e166 pathology 5:147e148, 5:151f physiology 5:150 prevalence of 5:145f preventive long-term immunotherapy 5:162e163 glatiramer acetate/copaxone 5:163 interferon beta 5:162e163 signs and symptoms 5:150e152 stem cells therapies 5:168 hematopoietic stem cell transplantation (HSCT) 5:168 symptomatic treatments 5:168e169 therapy of 5:158 treatment of acute deterioration/relapses of 5:158e162 corticosteroids 5:158e161 plasmapheresis 5:162 Primary health care (PHC) (continued) community participation 6:6, 6:9e10, 6:13 decentralized health systems 6:8 developing and promoting healthy policies and plans 6:10e11 development of comprehensive, community-based programs 6:11 district health system, subdistricts, and health centers 6:11e12 equity 6:6, 6:9e11 monitoring 6:12 and evidence 1:91 executive summary 1:92e94 globalization and 6:5 health centers (HCs) 6:12 health development 6:8, 6:11e13 Health for All (HFA) 6:5e6, 6:12 health sector reform 6:8e9 human resource development for primary health care 6:12e13 human resources for health (HRH) 6:12 implementation 1:91 intersectoral collaboration 6:9 locating in new paradigm 1:92 mental health services in 5:49 monitoring equity in health and health care 6:12 Ottawa Charter 6:7 PHC approach (PHCA) 6:9, 6:12 policy development 6:10e11, 6:13 resources for 6:18 revitalization of 6:9e13 and Sanders 1:90e91 selective PHC approach 6:9 alcohol consumption and 6:58 anatomy, physiology, and pathology 6:51e52 diagnosis, screening, and treatment 6:52e53 future prospects 6:58 Gleason grading system 6:52f histopathology 6:53 insulin-like growth factor 6:55e56 obesity 6:55e57 occupation 6:58 probability of detecting 1:231 prostate specific antigen (PSA) 6:52e54 radiation 6:58 risk factors for 6:55e58dietary and nutritional factors 6:57e58 family history and genetic factors 6:55 hormones 6:55e56 infection and inflammation 6:56e57 sexual activity 6:56 screening 1:400e401 adverse effects 1:401 effectiveness 1:400e401 PSA 1:400 tests 1:401 smoking and 6:58 variation in incidence and mortality 6:53e54 abnormal pubertal development 6:145e146 adolescence 6:143, 6:145e146 adrenarche 6:143e144, 6:146 definition 6:143 delayed 6:146 disorders of sexual development 6:146 gonadarche 6:143e144 growth 6:143e144, 6:146 hair development 6:144 leptin 6:144e145 menarche 6:143e146 physiological changes 6:143e144 reproductive health 6:146 secondary sexual characteristics 6:143e145 secular trends 6:144e145 variation within the normal range 6:145 Pubic lice 2:421 Public and consumer participation in policy and research 6:148e157 accumulation and interpretation of knowledge 6:155 assessing health needs 6:152e153 assessing how solutions operate 6:153 community engagement in public health 6:152f consumer involvement 6:150 degrees of participation 6:150e151 developing and assessing solutions 6:153 eParticipation 6:150 evidence-based public health 6:148e149 evidence-informed participatory approaches to public health 6:148e149 evidence-informed public health 6:148 forums and methods for participation 6:151 individual and collective participation 6:151 interventions for and with the public 6:148 making change happen 6:153e155 making public participation in public health happen 6:156 participants 6:149e151Public and consumer participation in policy and research (continued) participation in practice 6:151e152 principles of participation 6:151 public health, politics, and science 6:148 public involvement 6:149e150 research/service cycles 6:155 schematic of the drivers, process, and impacts 6:154f theories of participation 6:150 Public health 2:223e225, 5:211, 7:407 anthropology of human reproduction 2:189 applications of public health knowledge 6:159e160 challenges in 6:160e163 communication, culture in in crisis situations 2:204e205 community engagement in 6:152f conceptual distinction between clinical medicine and 2:224 concerns after disaster 5:220 access to water 5:220 communicable diseases 5:220 food shortages 5:220 housing issues 5:220 sanitation crisis 5:220 definition 6:158, 6:210 emergencies 3:15 history 6:158 and human rights 5:568e569 imprisonment and human rights 5:568 imprisonment and public health 5:568e569 impact of chronic diseases 2:22 legislative and administrative developments 6:211 managed care and 4:542 measures 5:89e90 reduction of suicide and homicide by mentally ill people 5:89e90 measures to prevent environmental mycobacterial disease 5:262 methods of investigation in 6:158 multi-disciplinary expertise 6:158e159 new public health 6:158 occupational health 5:327e329 passive understanding of 6:148 physical activity 1:31 as a profession 6:210e211 professionalization of 6:211 public participation in 6:156 responses, violence/intentional injuries 7:349e350 understanding of justice in 6:320 Public health, psychoactive substances 6:169, 6:176e177, 6:179fdeterminants of benefits and harms of 6:171e176, 6:174f availability and accessibility 6:175 context of substances taking 6:175e176 demand 6:175 governance structures 6:175 health, social, and criminal justice services 6:176 deaths 6:237f, 6:238 'furious' human form 6:239e240, 6:239fe240f incidence rate 6:237e238 intradermal vaccines 6:243 intramuscular injections of vaccine 6:243 laboratory diagnosis 6:240e241 major animal vectors 6:237f management of human 6:243e244 paralytic form 6:240, 6:240f phobic spasms in 6:240 postexposure prophylaxis (PEP) 6:236, 6:241e243, 6:241t postexposure vaccine schedules, WHO approved 6:242e243 pre-exposure vaccination 6:243 rapid ante-mortem laboratory diagnosis 6:241 transmission 6:236e238 vaccines 6:242t, 6:243 Racecadotril 7:366 Race/racism 6:249e250 among indigenous populations 5:578 causal pathways 6:245 conceptualizing 6:249e250 conflating human genetic variation and 6:247 conflating lived experience and genetics 6:247 coping 6:254e255 denial of 6:252 discrimination 6:249e254, 6:250f ethnicity 6:249 versus evolution 6:246 future directions 6:255e256 genetics 6:245e246 and health 6:249e259 health and well-being 6:253e254 direct studies of racism and health 6:254 indirect studies of racism and health 6:253e254 reaction/responses to racism and health 6:254e255 health disparities 6:245, 6:247 and health inequalities 6:245 and human genetic variation 6:246e247 lived experience of racialization and racism 6:245e246 measuring 6:250e251 medical sciences and technology 5:15e16 and mental disorders 5:70 mortality 6:245 operationalizing 6:251e253 oppression 6:249e250 perception, attribution, and reporting of 6:251 privilege 6:249 raciogenetic perspective 6:245 segregation 6:253 stress 6:250e251, 6:254e256 structure of human variation 6:246e247 human traits vary independently from each other 6:246 human variation is continuous 6:246 building-related illness 6:503e504 causes 6:502 definition 6:502 indoor air quality 6:505 psychosocial factors 6:502, 6:504 symptoms 6:502 Sickle cell anemia (SCA) 2:245, 5:15, 6:508 Sickle-cell disease 1:247, 6:506e508 acute chest syndrome 6:509e510, 6:510t anemia 6:508 complications acute and chronic bone disease 6:510 acute and chronic lung disease 6:509e510 central nervous system damage 6:510 chronic heart disease 6:510 eye disease 6:510 hemolytic anemia 6:509 kidney disease 6:509 leg ulceration 6:510 liver disease 6:510 pregnancy 6:510e511 priapism 6:511 recurrent infections 6:509 sickle cell crises 6:509 genetics 6:507 hemoglobin 6:506 hemoglobinopathy 6:508 hyposthenuria 6:509 leg ulcer 6:510 osteonecrosis 6:510 pathophysiology 6:507e508 pulmonary hypertension 6:509e510 sickle cell trait 6:509 stroke 6:510 thalassemia 6:508 acquisition 6:2 Australia 6:3 California 6:2e3 cancer 6:545e546, 6:549 cardiovascular disease 6:545, 6:548 and cardiovascular disease 3:314e316, 3:322 cessation 5:312, 6:3 disease causation 6:549 emerging evidence 6:2e3 exposure to accumulated smoking hazards 6:545e546 factors not related to 4:479 and gastric cancer 3:220 health promotion for adolescents 6:2 influences leading to the first cigarette 6:2 intergenerational patterns of 6:1e2 misguided past 6:1e2 mortality 6:548 neglected opportunity 6:2 and pancreatic cancer 5:391 peripheral arterial disease and 5:451 population attributable fraction (PAF) 6:546, 6:549 population health 6:545e546, 6:549 prevalence 6:1e3 and prostate cancer 6:58 reducing the prevalence of 4:483 relative risks (RRs) 6:546e548 respiratory disease 6:548 school-based intervention 6:2 social norms 6:2e3 sources of uncertainty 6:549 teenagers 6:1e2 tobacco control 6:1e3 tobacco-attributable mortality 6:546 trends 6:3 way forward 6:3Smoking and alcohol-free workplaces alcohol, evidence on 2:371 tobacco, evidence on 2:370e371 Smoking cessation 6:534 assistance 6:541 behavioral interventions 6:538e539 harm reduction 6:541 nicotine 6:534e535 drug dependence 6:535 measuring dependence 6:535e536 replacement therapy 6:538e540 transition 6:535 withdrawal syndrome 6:536 non-nicotine therapies without proven efficacy 6:540e541 pharmacotherapies with proven efficacy 6:539e540 populations 6:542e543 prevention 6:543 public health approach programs 6:536 quitting 6:536e538 self-help approaches to quitting 6:538 Alma-Ata conference 6:557 CSDH 6:560 action 6:559e560 civil society 6:560 knowledge networks 6:559 health equity agenda 6:557 Health for All 6:557 health gaps and gradients 6:559 health system 6:558e559 intersectoral action 6:559e560 primary health care 6:557 public policy approaches 6:560 rationale and goal 6:557 structural and intermediary determinants 6:558 World Health Organization (WHO) 6:557 Social dimensions of epidemics 6:562e566 collective informed consent 6:566 community-level predictors 6:563e566 cultural practices and customs 6:563 distribution of information 6:565 public image of a disease 6:563e564 social factors or predictors of successful management of epidemics 6:562e563 stigma attached to a disease 6:563e564 subjective perception of severity and susceptibility 6:563Social dimensions of epidemics (continued) transparency of government actions and decision-making 6:564 trust in health authorities 6:565e566 Social disintegration 3:38 Social disruption, importance of 2:193 Social drift 5:70 Social epidemiology 6:574connections 6:580e582 diachronic processes 6:583e584 discrimination 6:582 general association 6:578e580 income inequality 6:578 measurement 6:576e578, 6:580e583 organization levels 6:582e583 origins 6:575 poverty 6:575e576 risk factor 6:575e576 social class 6:575e577, 6:583e584 social networks 6:574, 6:580e582 socioeconomic position and health outcomes 6:576e578 sociology 6:575 Social exclusion 5:561 and homelessnes 5:557e558, 5:561 Social factors or predictors of successful management of epidemics 6:562e563 Social gradients, child 6:586e589 attributable risks of ill health 6:593, 6:596 health services 6:595e596 individual health 6:592e595 pathways 6:590e592 population health 6:592e595 relative 6:586e587, 6:589e590, 6:593 role of policy 6:595 subsequent health 6:589e590 universal primary care services 6:595e596 universal social programs 6:595 Social health governance in health finance 3:330e331 Stigma 3:508, 6:40 addressing 5:90 antistigma campaigns contact 6:48e49 education 6:47e48 protest 6:47 attached to a disease 6:563e564 categorical versus dimensional 6:41e42 child and adolescent mental disorders 7:25 concealability 6:42 defined 5:77 definitions 6:40e41 and discrimination 5:43 epilepsy 6:463e464 Goffman model 6:42 health and recovery 6:46e47 and health services access 3:509e510 and homelessnes 5:557e558 and human rights violations 5:46e47 and illness 3:508e509 advertising 7:170e171 cessation 7:172 control 7:177 countermarketing 7:171e172 demand reduction 7:169e172 harm reduction 7:169e170, 7:170t, 7:174e177 licensing and product tracking 7:173 lower-risk products 7:176e177 nicotine 7:172e177, 7:172t pack warnings 7:171 product bans 7:172e173 product regulation 7:174e176 public health 7:173e175 smoke-free 7:174 smoking 7:170e172, 7:174 smoking cessation 7:171e172, 7:176 taxation 7:170 trade policies and industry configuration 7:173e174 youth access laws 7:174 industry adverse environmental and occupational health impacts 3:296 assets 3:292, 3:294, 3:297e298 brands 3:294 capital 3:292e293, 3:296e297 characteristics 3:293 CNTC 3:293e294 deforestation 3:296 documentation 3:296 endgames 3:297e298 FCTC 3:296 globalization 3:292 globalized industry 3:292 :196, 7:198, 7:200e201, 7:200e203 Russia 7:198e199 Soviet Union and Eastern Europe 7:200e201 taxation 7:195, 7:201, 7:203 technical concerns 7:196 United Kingdom 7:198 user charges 7:195, 7:201 Universal precautions (UPs) HIV 4 child labor and health 5:622e623 downsizing and health 5:618, 5:623e624 gender, precarious work, and health 5:625 informal employment and health 5:622 job insecurity and health 5:624e625 precarious employment and health 5:621e622 slavery and health 5:623 unemployment and health 5:620e621 flexicurity 5:618 globalization and flexibility 5:617e618 health and safety 2:507, 7:444e445 interventions 5:625e626 job insecurity 5:618 labor market 5:617 precarious employment, dimensions of 5:619e620 role in occupational injury prevention 5:338 social support model 5:620e621 working conditions 5:617, 5:621e623 Working conditions 5:617, 5:621e623 Workplace violence (WPV) 5:339e341 defined 7:345t definitions and classification of typologies 5:339 extent of problem 5:339 prevention approaches 5:340e341 risk factors 5:340 role of surveillance 5:339e340 Workplaces health promotion in 3:454 mental/physical health promotion 5:84 and work-road injuries 5:315 Work-related fatal injuries 5:317t by age 5:318f Work-related injury and disease deaths 5:316 common characteristics of 5:316e321 Work-related MSDs 2:577 Work-related risk factors for musculoskeletal disorders 2:579t Worksites physical activity and 5:469 challenges to disseminating successful models 7:509 defined 7:345t health consequences of 7:502 homicide rates 7:502 interventions to prevent 7:506e508, 7:506t extrafamilial 7:507e508 family-level 7:506e507 individual-level 7:506 principles of effective 7:509 magnitude of 7:502e503 prevention interventions 7:357 public health approach to prevention 7:502 rate of serious violent crime 7:503 risk and protective factors for 7:503e506, 7:505t extrafamilial 7:504e505 family 7:504 individual 7:503e504 multiple opportunities for prevention 7:505e506 violence of war and armed conflict 7:503 Z ",
            "cite_spans": [
                {
                    "start": 513,
                    "end": 519,
                    "text": "(MERS)",
                    "ref_id": null
                },
                {
                    "start": 585,
                    "end": 589,
                    "text": "449,",
                    "ref_id": null
                },
                {
                    "start": 590,
                    "end": 596,
                    "text": "4:222,",
                    "ref_id": null
                },
                {
                    "start": 597,
                    "end": 603,
                    "text": "6:351,",
                    "ref_id": null
                },
                {
                    "start": 604,
                    "end": 610,
                    "text": "6:354,",
                    "ref_id": null
                },
                {
                    "start": 611,
                    "end": 625,
                    "text": "7:368 Migraine",
                    "ref_id": null
                },
                {
                    "start": 2028,
                    "end": 2045,
                    "text": "536, 5:592, 7:437",
                    "ref_id": null
                },
                {
                    "start": 2825,
                    "end": 2848,
                    "text": "(accidents, explosions)",
                    "ref_id": null
                },
                {
                    "start": 15661,
                    "end": 15666,
                    "text": ":196,",
                    "ref_id": null
                },
                {
                    "start": 15667,
                    "end": 15673,
                    "text": "7:198,",
                    "ref_id": null
                },
                {
                    "start": 15674,
                    "end": 15684,
                    "text": "7:200e201,",
                    "ref_id": null
                },
                {
                    "start": 15685,
                    "end": 15769,
                    "text": "7:200e203 Russia 7:198e199 Soviet Union and Eastern Europe 7:200e201 taxation 7:195,",
                    "ref_id": null
                },
                {
                    "start": 15770,
                    "end": 15776,
                    "text": "7:201,",
                    "ref_id": null
                },
                {
                    "start": 15777,
                    "end": 15848,
                    "text": "7:203 technical concerns 7:196 United Kingdom 7:198 user charges 7:195,",
                    "ref_id": null
                },
                {
                    "start": 15849,
                    "end": 15882,
                    "text": "7:201 Universal precautions (UPs)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}